Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 20/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7062402 | 1.00 | MME (0.66) | MME | |
| SCHEMBL7066246 | 1.00 | MME (0.66) | MME | |
| SCHEMBL7065545 | 0.91 | MME (0.64) | MME | |
| SCHEMBL7159322 | 0.86 | MME (0.51) | MME | |
| SCHEMBL489205 | 0.80 | MME (1.00) | MME | |
| SCHEMBL6340259 | 0.80 | MME (0.82) | MME | |
| SCHEMBL6349761 | 0.80 | MME (1.00) | MME | |
| SCHEMBL1620495 | 0.80 | MME (1.00) | MME | |
| SCHEMBL7070170 | 0.78 | MME (0.58) | MME | |
| SCHEMBL7070168 | 0.78 | MME (0.58) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030105097-A1 | Alkylamide compounds | PFIZER INC. | 2003-06-05 | — | — | US | claimed |
| EP-1258474-A2 | Alkylamide compounds | Pfizer Limited (GB) | 2002-11-20 | — | — | EP | claimed |
| US-20030105097-A1 | Alkylamide compounds | PFIZER INC. | 2003-06-05 | — | — | US | disclosed |
| EP-1258474-A2 | Alkylamide compounds | Pfizer Limited (GB) | 2002-11-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105097-A1 | Alkylamide compounds | CBR1, CNR1, CBR3 | MME 3141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.